OncoGenomX AG

OncoGenomX AG provides PredictionStar, a therapy decision-support tool for breast cancer that analyzes tumor-specific genomic, biological, pathological and clinical data to inform treatment composition. The point-of-care platform applies patented algorithms and machine-learning–assisted drug–tumor matching, delivers analysis reports within the hospital IT environment without additional invasive procedures, and is designed for routine clinical use.